Q3 2019

Filed Mar 9, 2020 · 10-Q · 161 days after period end · 0001121781-20-000018

Q3 2019 · 10-Q

Revenue

$1.00K

−50.0% vs Q3 2018

Net Income

-$126.00K

N/M vs Q3 2018

EPS Diluted

-$0.04

N/M vs Q3 2018

Gross Profit$1,000−50.0%

Operating Income

Same quarter

Metric	Q3 2019	Q3 2018	Q3 2017	Q3 2016
Revenue	$1.00K	$2.00K	$33.00K	$95.00K
Net Income	-$126.00K	-$746.00K	-$2.37M	-$211.00K
EPS Diluted	-$0.04	-$1.60	-$0.35	-$1.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR